| Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial M Valgimigli, A Gagnor, P Calabró, E Frigoli, S Leonardi, T Zaro, ... The Lancet 385 (9986), 2465-2476, 2015 | 1391 | 2015 |
| Bivalirudin or unfractionated heparin in acute coronary syndromes M Valgimigli, E Frigoli, S Leonardi, M Rothenbühler, A Gagnor, P Calabrò, ... New England Journal of Medicine 373 (11), 997-1009, 2015 | 402 | 2015 |
| Dual antiplatelet therapy after PCI in patients at high bleeding risk M Valgimigli, E Frigoli, D Heg, J Tijssen, P Jüni, P Vranckx, Y Ozaki, ... New England Journal of Medicine 385 (18), 1643-1655, 2021 | 316 | 2021 |
| Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a … M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ... The Lancet 392 (10150), 835-848, 2018 | 275 | 2018 |
| The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm … E Arbelo, J Brugada, G Hindricks, AP Maggioni, L Tavazzi, P Vardas, ... European heart journal 35 (22), 1466-1478, 2014 | 251 | 2014 |
| Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX G Andò, B Cortese, F Russo, M Rothenbühler, E Frigoli, G Gargiulo, ... Journal of the American College of Cardiology 69 (21), 2592-2603, 2017 | 153 | 2017 |
| Radiation exposure and vascular access in acute coronary syndromes: the RAD-Matrix trial A Sciahbasi, E Frigoli, A Sarandrea, M Rothenbühler, P Calabrò, A Lupi, ... Journal of the American College of Cardiology 69 (20), 2530-2537, 2017 | 89 | 2017 |
| Prognostic implications of declining hemoglobin content in patients hospitalized with acute coronary syndromes S Leonardi, F Gragnano, G Carrara, G Gargiulo, E Frigoli, P Vranckx, ... Journal of the American College of Cardiology 77 (4), 375-388, 2021 | 83 | 2021 |
| MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial M Valgimigli, A Gagnor, P Calabró, E Frigoli, S Leonardi, T Zaro, ... Lancet 385 (9986), 2465-2476, 2015 | 76 | 2015 |
| Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial S Leonardi, E Frigoli, M Rothenbühler, E Navarese, P Calabró, P Bellotti, ... bmj 354, 2016 | 66 | 2016 |
| Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation P Vranckx, E Frigoli, M Rothenbühler, F Tomassini, S Garducci, G Andò, ... European Heart Journal 38 (14), 1069-1080, 2017 | 62 | 2017 |
| Effects of ticagrelor, prasugrel, or clopidogrel on endothelial function and other vascular biomarkers: a randomized crossover study S Ariotti, L Ortega-Paz, M van Leeuwen, S Brugaletta, S Leonardi, ... JACC: Cardiovascular Interventions 11 (16), 1576-1586, 2018 | 57 | 2018 |
| Scientific foundation and possible implications for practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX … M Valgimigli, P Calabrò, B Cortese, E Frigoli, S Garducci, P Rubartelli, ... Journal of cardiovascular translational research 7, 101-111, 2014 | 55 | 2014 |
| Irrigated-tip magnetic catheter ablation of AF: a long-term prospective study in 130 patients C Pappone, G Vicedomini, E Frigoli, L Giannelli, C Ciaccio, M Baldi, ... Heart rhythm 8 (1), 8-15, 2011 | 53 | 2011 |
| Design and rationale of the management of high bleeding risk patients post bioresorbable polymer coated stent implantation with an abbreviated versus standard DAPT regimen … E Frigoli, P Smits, P Vranckx, Y Ozaki, J Tijssen, P Jüni, MC Morice, ... American heart journal 209, 97-105, 2019 | 52 | 2019 |
| Abbreviated antiplatelet therapy in patients at high bleeding risk with or without oral anticoagulant therapy after coronary stenting: an open-label, randomized, controlled trial PC Smits, E Frigoli, J Tijssen, P Jüni, P Vranckx, Y Ozaki, MC Morice, ... Circulation 144 (15), 1196-1211, 2021 | 49 | 2021 |
| Impact of sex on comparative outcomes of radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: data from the randomized MATRIX … G Gargiulo, S Ariotti, P Vranckx, S Leonardi, E Frigoli, N Ciociano, ... JACC: Cardiovascular Interventions 11 (1), 36-50, 2018 | 49 | 2018 |
| Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis M Valgimigli, PC Smits, E Frigoli, D Bongiovanni, J Tijssen, T Hovasse, ... European heart journal 43 (33), 3100-3114, 2022 | 44 | 2022 |
| Bivalirudin or heparin in patients undergoing invasive management of acute coronary syndromes G Gargiulo, G Carrara, E Frigoli, P Vranckx, S Leonardi, N Ciociano, ... Journal of the American College of Cardiology 71 (11), 1231-1242, 2018 | 39 | 2018 |
| Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI‐MATRIX (acute kidney injury‐minimizing adverse hemorrhagic events by TRansradial access site … G Andò, B Cortese, E Frigoli, A Gagnor, S Garducci, C Briguori, ... Catheterization and Cardiovascular Interventions 86 (5), 950-957, 2015 | 36 | 2015 |
